Biglycan evokes autophagy in macrophages via a novel CD44/Toll-like receptor 4 signaling axis in ischemia/reperfusion injury - ScienceDirect
Toll-like receptor 2 orchestrates a tumor suppressor response in non-small cell lung cancer - ScienceDirect
A Map of Toll-like Receptor Expression in the Intestinal Epithelium Reveals Distinct Spatial, Cell Type-Specific, and Temporal Patterns - ScienceDirect
Crosstalk between Complement and Toll-Like Receptors - Wen-Chao Song, 2012
Toll-like receptor 9 (TLR9) agonists in the treatment of cancer | Oncogene
Toll-like receptor 4: An attractive therapeutic target for acute kidney injury - ScienceDirect
Toll-like Receptor 5 Activation by the CagY Repeat Domains of Helicobacter pylori - ScienceDirect
Frontiers | Activation of Toll-Like Receptors by Live Gram-Negative Bacterial Pathogens Reveals Mitigation of TLR4 Responses and Activation of TLR5 by Flagella
Toll-like receptor 4 signaling pathway mediates both liver and kidney injuries in mice with hepatorenal syndrome | American Journal of Physiology-Gastrointestinal and Liver Physiology
Tumor Lysis Syndrome - EMCrit Project
Tumor Lysis Syndrome - LearnPICU
Toll-like Receptor 2-Dependent NF-κB/AP-1 Activation by Damage-Associated Molecular Patterns Adsorbed on Polymeric Surfaces | ACS Biomaterials Science & Engineering
Toll-like Receptor 7 (E4J3Z) Rabbit mAb | Cell Signaling Technology
Negative regulation of Toll-like receptor 4 (TLR4) signaling. Proteins... | Download Scientific Diagram
Frontiers | Toll-like receptor-mediated innate immunity orchestrates adaptive immune responses in HBV infection
Prosaposin promotes the proliferation and tumorigenesis of glioma through toll-like receptor 4 (TLR4)-mediated NF-κB signaling pathway - eBioMedicine
Cancers | Free Full-Text | Toll-like Receptors from the Perspective of Cancer Treatment
Toll-like receptors and cancer | Nature Reviews Cancer
Cancers | Free Full-Text | Toll-like Receptors from the Perspective of Cancer Treatment
Frontiers | Cell Surface Expression of Endosomal Toll-Like Receptors—A Necessity or a Superfluous Duplication?
IJMS | Free Full-Text | Toll-Like Receptor 2 at the Crossroad between Cancer Cells, the Immune System, and the Microbiota
IJMS | Free Full-Text | The Role of Toll-like Receptors (TLRs) Mediated Inflammation in Pancreatic Cancer Pathophysiology
Microorganisms | Free Full-Text | The Role of Toll-Like Receptors in Retroviral Infection
Cancers | Free Full-Text | Toll-like Receptors from the Perspective of Cancer Treatment
Toll-like receptor agonists: current status and future perspective on their utility as adjuvants in improving antic ancer vaccination strategies | Immunotherapy
Toll-Like Receptors in Natural Killer Cells and Their Application for Immunotherapy
Interleukin Receptor Associated Kinase 1 Signaling and Its Association with Cardiovascular Diseases
Tumor Lysis Syndrome. Usually occurs c/n 1-5 days post-chemo tx. | Tumor lysis syndrome, Chemo nursing, Emergency nursing
Dual Toll-Like Receptor Targeting Liposomal Spherical Nucleic Acids | Bioconjugate Chemistry
